Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is McKesson Corporation (MCK) A Good Stock To Buy?

Page 1 of 3

Even though the market recovered from the third-quarter slump during the last three months of 2015, with the S&P 500 gaining around 8% between October and December, the decline in oil prices and fears of a slowdown in global economic growth still creates some uncertainty for investors. Among the funds we track, we also noticed some interesting trends and in this article, we are going to take a closer look at the smart money sentiment towards McKesson Corporation (NYSE:MCK), according to the latest round of 13F filings.

McKesson Corporation (NYSE:MCK) shareholders have witnessed a decrease in hedge fund interest lately. At the end of this article we will also compare MCK to other stocks, including The Bank of New York Mellon Corporation (NYSE:BK), Target Corporation (NYSE:TGT), and Statoil ASA (ADR) (NYSE:STO) to get a better sense of its popularity.

Follow Mckesson Corp (NYSE:MCK)
Trade (NYSE:MCK) Now!

In the eyes of most traders, hedge funds are perceived as unimportant, outdated financial vehicles of years past. While there are over 8000 funds trading at present, We choose to focus on the elite of this group, approximately 800 funds. These investment experts preside over the majority of all hedge funds’ total capital, and by paying attention to their finest equity investments, Insider Monkey has formulated a number of investment strategies that have historically surpassed Mr. Market. Insider Monkey’s small-cap hedge fund strategy outstripped the S&P 500 index by 12 percentage points per year for a decade in their back tests.

One of the funds betting on McKesson is Herbert Abramson and Randall Abramson’s Trapeze Asset Management, which discussed the company in its third-quarter letter to investors. Read on to see the fund’s comments.

Page 1 of 3

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!